Children at high risk for RSV are eligible for immunoprophylaxis administration during seasonal spikes, and guidelines recommend they receive RSV monoclonal antibodies.
Study: RSV pattern changed during COVID-19 pandemic
More from COVID-19More posts in COVID-19 »